Future research will be definitively focused on further understanding the role of cGAS-STING signaling in ALS, as well as in Parkinson’s disease and other neurodegenerative and autoimmune disorders in order to translate STING antagonists from laboratory research to the patients. The gene discussed is STING1; the disease is autoimmune disease.